VERIFY: Did Trump end the $35 monthly insulin cap?

📚 Main Topics

President Trump signed several executive orders during his first week back in office, but none of these orders ended the $35 monthly cap on insulin prices for Medicare recipients.
The $35 cap on insulin was established through the Inflation Reduction Act, meaning it would require new legislation from Congress to alter or eliminate it.
Eli Lilly, a private drug manufacturer, has also implemented a $35 cap on insulin for those with commercial insurance and offers a savings card for uninsured individuals.

Claims circulating on social media regarding changes to healthcare policies should be verified with credible sources.
Legislative changes, especially regarding healthcare pricing, often require formal processes and cannot be altered solely through executive orders.
Understanding the roles of both government and private entities in healthcare pricing is crucial for consumers, especially those reliant on essential medications like insulin.